Added to YB: 2025-04-16
Pitch date: 2025-04-13
HIMS [neutral]
Hims & Hers Health, Inc.
-29.21%
current return
Author Info
Capitalist Letters simplifies investing and makes it understandable for everybody. Sign up for the newsletter.
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$28.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
growth
Our Shopping List of Tariff Proof Stocks! - Hims & Hers Health, Inc.
HIMS (buy at $22): DTC telehealth leader, 77% 5-yr rev CAGR, 8.5% profit margin, 30% ROE. 50%+ subscribers on personalized plans. Acquired peptide facility to produce own ingredients (Semaglutide, weight-loss, T-boosters) insulating from tariff impact while competitors struggle. $26/$22 buy zones, adding at $22.
Read full article (1 min)